Bromfenac
From Wikipedia, the free encyclopedia
|
Bromfenac
|
|
| Systematic (IUPAC) name | |
| 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C15H12NO2 |
| Mol. mass | 383.17 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | Oral (discontinued) ophthalmic |
Bromfenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription capsule (discontinued; brand name Duract) or as an ophthalmic solution (brand name Xibrom).
[edit] External links
|
|||||||||||||||||||||||||||||||||||

